B-cell leukemia protein-2 and peptide YY chemotherapy resistance in colon cancer

American Journal of Surgery

Volumn 178, Issue 5, 1999, Pages 411-414

  Kling, Karen ^a   Kim, Frances ^a   Cole, Michael ^a   McFadden, David ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDE YY; PROTEIN BCL 2;

ARTICLE; CELL CULTURE; CELL SURVIVAL; CHEMOTHERAPY; COLON CANCER; CONTROLLED STUDY; DRUG RESISTANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR CELL LINE; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CELL SURVIVAL; COLONIC NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENES, BCL-2; HUMANS; PEPTIDE YY; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR CELLS, CULTURED;

EID: 0033429336     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(99)00209-3     Document Type: Article

References (23)

1. Bedi A., Pasricha P.J., Akhtar A.J., et al. Inhibition of apoptosis during development of colorectal cancer. Cancer Res. 55:1995;1811-1816.
2. Bargou R.C., Daniel P.T., Mapara M.Y., et al. Expression of the bcl-2 gene family in normal and malignant breast tissue low bax-alpha expression in tumor cells correlates with resistance towards apoptosis . Int J Cancer. 60:1995;854-859.
3. Teixeira C., Reed J.C., Pratt M.A. Estrogen promotes chemotherapeutic drug resistance by a mechanism involving bcl-2 proto-oncogene expression in human breast cancer cells. Cancer Res. 55:1995;3902-3907.
4. Bronner M.P., Cullin C., Reed J.C., Furth E.E. The bcl-2 proto-oncogene and the gastrointestinal epithelial tumor progression model. Am J Pathol. 146:1995;20-26.
5. Desoize B. Anticancer drug resistance and inhibition of apoptosis. Anticancer Res. 14:1994;2291-2294.
6. Sumantran V.N., Ealovega M.W., Nunez G., et al. Over-expression of bcl-xs sensitizes MCF-7 cells to chemotherapy-induced apoptosis. Cancer Res. 55:1995;2507-2510.
7. Sincrope F.A., Ruan S.B., Cleary K.R., et al. Bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res. 55:1995;237-241.
8. Hague A., Moorghen M., Hicks D., et al. Bcl-2 expression in human colorectal adenomas and carcinomas. Oncogene. 9:1993;367-370.
9. Maung Z.T., MacLean F.R., Reid M.M., et al. The relationship between bcl-2 expression and response to chemotherapy in acute leukemia. Br J Hematol. 88:1994;105-109.
10. Liu C.D., Rongione J.A., Garvey L., et al. Adjuvant hormonal treatment with peptide YY or its analog decreases human pancreatic carcinoma growth. Am J Surg. 17:1996;192-196.
11. Piazza G.A., Rahm A.L., Krutzsch M., et al. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res. 55:1995;3110-3116.
12. Smith M.R., Abubakr Y., Mohammad R., et al. Antisense oligodeoxyribonucleotide down-regulation of bcl-2 gene expression inhibits growth of the low-grade non-Hodgkin's lymphoma cell line WSU-FSCCL. Cancer Gene Ther. 2:1995;207-212.
13. Dole M.G., Jasty R., Cooper M.J., et al. Bcl-xl is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis. Cancer Res. 55:1995;2507-2510.
14. Minn A.J., Rudin C.M., Boise L.H., Thompson C.B. Expression of bcl-xl can confer multidrug resistance phenotype. Blood. 86:1995;1903-1910.
15. Kamesaki S., Kamesaki H., Jorgensen T., et al. bcl-2 protein inhibits etoposide-induced apoptosis through its effects on events subsequent to topoisomerase II-induced DNA strand breaks and their repair. Cancer Res. 53:1993;4251-4256.
16. Miyashita T., Reed J.C., Kitada S., Takayama S. bcl-2 oncoprotein blocks chemotherapy induced apoptosis in a human leukemia cell line. Blood. 81:1993;151-157.
17. Keith F.J., Bradbury D.A., Zhu Y.M., Russel N.H. Inhibition of bcl-2 with antisense oligonucleotides induces apoptosis and increases the sensitivity of AML blasts to Ara-c. Leukemia. 9:1995;131-138.
18. Sgambati S., Turowski G., Basson M. PYY selectively promotes expression of the colonocytic phenotype and stimulates proliferation of a human intestinal epithelial stem cell model. Surg Forum. 46:1995;179-182.
19. Korsmeyer S.J. Bcl-2 an antidote to programmed cell death. Cancer Surv. 15:1992;105-118.
20. Krajewski M., Krajewski S., Epstein J.I., et al. Immunohistochemical determination of invivo distribution of bax, a dominant inhibitor of bcl-2. Am J Pathol. 145:1994;1323-1336.
21. Kondo S., Yin D., Takeuchi J., et al. bcl-2 gene enables rescue from in vitro myelosuppression induced by chemotherapy. Br J Cancer. 70:1994;421-426.
22. Haldar S., Hegrini M., Monne M., et al. Down-regulation of bcl-2 by p53 in breast cancer cells. Cancer Res. 54:1994;2095-2097.
23. Gartel A., Serfas M., Gartel M., et al. p21 expression is induced in newly nondividing cells in diverse epithelia and during differentiation of the Caco-2 intestinal cell line. Exper Cell Res. 227:1996;171-181.